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Letters to the Editor
Difference between Mitochondrial RNase P and Nuclear RNase P
We previously demonstrated that mammalian cells contain
at least two distinct RNase P activities, one nuclear and one
mitochondrial (5, 7). These enzymes were shown to have dif-
ferent substrate specificities and distinct molecular and enzy-
matic properties (5–7). Puranam and Attardi recently reported
the purification of “nuclear” RNase P from mitochondrial
preparations (2). However, in the discussion of their findings
they made incorrect and misleading reference to previous work
on mitochondrial RNase P, necessitating a reevaluation of
their conclusions.
The presence of low levels of nuclear RNase P or other
nuclear RNA processing factors in purified mitochondrial
preparations is not a new observation, and digitonin treatment
is well-known to drastically reduce the levels of these contam-
inants (1, 3, 7). Mitochondrial RNase P activity, however, is
definitely independent of the presence or absence of nuclear
RNase P or its RNA component (H1 RNA) (7). Reduction of
contaminating nuclear RNase P by digitonin pretreatment of
mitochondria or its complete removal from mitoplast extracts
by either immunoprecipitation or purification did not result in
any change of mitochondrial RNase P activity in these prepa-
rations (7).
Yet, inevitably, Puranam and Attardi (2) failed in the iden-
tification of this RNase P activity independent of H1 RNA:
the use of Escherichia coli pre-tRNATyrsu3
 as a substrate
throughout their purification procedure made the assay of mi-
tochondrial RNase P activity naturally impossible. Mitochon-
drial RNase P as identified in 1995, which faithfully cleaves
mitochondrial tRNA precursors (3–7), does not process E. coli
pre-tRNATyrsu3
 (7). On the other hand, nuclear RNase P,
which is capable of cleaving pre-tRNATyrsu3
, does not cleave
mitochondrial pre-tRNATyr (7). Given the considerable struc-
tural differences between cytoplasmic and mitochondrial tRNAs,
this particularly useful distinction of mitochondrial and nuclear
RNase P by their substrate specificity is not surprising but
apparently is the result of the coevolution of enzymes and
substrates. Substrate recognition of both enzymes nevertheless
overlaps as long as the precursors fulfill the respective struc-
tural requirements (7).
Thus, is it possible that mammalian mitochondria contain
two forms of RNase P, one distinct from and one identical to
the nuclear enzyme? Such a scenario of two RNase P enzymes
within one cellular compartment would be without precedent
and therefore requires careful evaluation. Of course, the rel-
ative and absolute levels of both enzymes in mitochondria are
critical in this argument. Even in small amounts of crude mi-
tochondrial extracts, detection of mitochondrial RNase P ac-
tivity appears to be straightforward, thereby indicating a high
level of enzyme (7). In contrast, nuclear RNase P activity could
not be detected in mitochondrial extracts (7) but required
enrichment by biochemical purification to allow assay of its
activity (2). Puranam and Attardi nevertheless provided an
estimate of the quantities of nuclear RNase P (H1) RNA as
well as other snRNAs present in purified mitochondria (2).
Taking their numbers for granted, (i) the actual levels of U
snRNAs (nuclear splicing factors) and H1 RNA are in an
astonishingly similar range and (ii) the estimated number of
H1 RNA molecules in the mitochondrial matrix (digitonin/
micrococcal nuclease resistant and “corrected for losses of
mitochondrial markers”) of cells in the G2 phase of the cell
cycle is only one-third of the number of mitochondria (2). The
latter implies that the mitochondria of cells during other
phases of the cell cycle do not contain any nuclear RNase P,
which would only be possible by cell cycle stage-dependent
import of nuclear RNase P followed by rapid intramitochon-
drial degradation or expulsion. Moreover, assuming that this
scenario is correct, the numbers given by Puranam and Attardi
would actually be overestimates of RNase P amounts, as their
preparations were “enriched in heavy mitochondria” (2). Thus
we feel that although it is impossible to formally exclude the
possibility that mitochondria contain trace amounts of nuclear
RNA processing factors, contamination of mitochondrial prep-
arations during subcellular fractionation still appears to be the
more plausible interpretation.
REFERENCES
1. Kiss, T., and W. Filipowicz. 1992. Evidence against a mitochondrial location
of the 7-2/MRP RNA in mammalian cells. Cell 70:11–16.
2. Puranam, R. S., and G. Attardi. 2001. The RNase P associated with HeLa cell
mitochondria contains an essential RNA component identical in sequence to
that of the nuclear RNase P. Mol. Cell. Biol. 21:548–561.
3. Rossmanith, W. 1996. Ph.D. thesis. University of Vienna, Vienna, Austria.
4. Rossmanith, W. 1997. Processing of human mitochondrial tRNASer(AGY): a
novel pathway in tRNA biosynthesis. J. Mol. Biol. 265:365–371.
5. Rossmanith, W., and R. M. Karwan. 1998. Characterization of human mito-
chondrial RNase P: novel aspects in tRNA processing. Biochem. Biophys.
Res. Commun. 247:234–241.
6. Rossmanith, W., and R. M. Karwan. 1998. Impairment of tRNA processing by
point mutations in mitochondrial tRNALeu(UUR) associated with mitochon-
drial diseases. FEBS Lett. 433:269–274.
7. Rossmanith, W., A. Tullo, T. Potuschak, R. Karwan, and E. Sbisa`. 1995.
Human mitochondrial tRNA processing. J. Biol. Chem. 270:12885–12891.
Walter Rossmanith*
Institute of Anatomy
University of Vienna
Wa¨hringer Str. 13
1090 Vienna, Austria
Thomas Potuschak
ICMB
University of Edinburgh
Edinburgh EH9 3JR, Scotland, United Kingdom
*Phone: 43 1 4277 61187
Fax: 43 1 4277 61198
E-mail: walter.rossmanith@univie.ac.at
Authors’ Reply
In earlier work (1), we showed that HeLa cell mitochondria
carry a micrococcal nuclease-sensitive RNase P activity repre-
senting a fraction of a percent of the total activity in the
postmitochondrial cytosol fraction (consisting mostly of the
leaked-out nuclear activity). In agreement with this result, we
recently demonstrated that highly purified HeLa cell mtRNase
P contains an intact RNA identical to H1 RNA of nuclear
RNase P, representing 0.3% of that associated with the
nucleocytosolic compartment; crucially, this RNA can be re-
moved from mitochondria only by treatments destroying the
integrity of the organelles (6). That mitochondria carry such a
small amount of RNase P is not surprising, knowing that they
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contain only 1% of the cell tRNAs (2). Most significantly, an
analysis of the expected functional requirements for tRNA
processing in HeLa cell mitochondria showed that the detected
level of mtRNase P fully satisfies those requirements (6).
Our conclusions are in apparent contrast with the results of
Rossmanith and colleagues, who described an abundant re-
portedly RNA-free mtRNase P (7, 8). Our failure to detect
such enzyme was not due to using E. coli ptRNATyr as a
substrate. In fact, contrary to a statement in their letter, this
substrate was clearly cleaved by their mtRNase P, although
incorrectly, i.e., four nucleotides upstream of the mature 5
end (7). No such processing activity was observed at any stage
during purification of our mtRNase P, and we would have
definitely been able to see it (6).
In answer to another statement in the letter, the proportions
of total cell- and washed mitochondrion-associated U snRNAs
(which is a more appropriate parameter than “levels”) that we
found in purified mitochondria were, respectively, 1 and 2
orders of magnitude lower than the corresponding proportions
of H1 RNA. Also, our most conservative estimate of mitochon-
drial H1 RNA amount per cell in unsynchronized cells, which
quantifies only intact H1 RNA (175 molecules), when re-
ferred to transcriptionally active cells (5), would be about twice
the number of mitochondria per cell.
There are two obvious differences in the experiments by
Rossmanith et al., as compared to ours. (i) The first difference
is the quality of their mitochondrial preparations, which exhib-
ited a massive degradation of their abundant nuRNase P con-
taminant, as well as of their mitochondrial RNAs (as ex-
emplified by tRNAGlu). This degradation, which resulted
presumably from those authors’ use of frozen cells for cell
fractionation and from the expected consequent molecular
damage, contrasts dramatically with our patterns of mostly
intact RNA. This damage could account for the differences in
enzymatic and physical properties and in RNA content of their
RNase P. (ii) The second difference is the lack of any clearly
interpretable quantification of RNase P activity and RNA con-
tent. In particular, in their most recent paper (8), Rossmanith
et al. acknowledged the presence of degraded RNA in their
partially purified mtRNase P, but no quantification was pre-
sented. It is well established that yeast mtRNase P retains
partial activity after extensive degradation of its mtDNA-en-
coded RNA (3).
As to the physiological significance for HeLa cells of the
presence of a limiting, though adequate, amount of RNase P in
mitochondria, which we determined by two independent ap-
proaches, it is important to point out that the RNase P tRNA
processing sites are the sites of polyadenylation, and resulting
stabilization, of the upstream encoded RNAs (4, 6). Thus,
limiting the amount of RNase P in mitochondria to the mini-
mum required for tRNA synthesis would not allow stabiliza-
tion of the 10- to 15-fold excess of fast turning-over nascent
L-strand transcripts and prevent both a disproportionately
high rate of synthesis of the eight L-strand-encoded tRNAs
relative to the H-strand-encoded tRNAs, which could nega-
tively affect translation (2), and an accumulation of abundant
antisense RNA.
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